Dr. Abraham Morgentaler, a Blavatnik Faculty Fellow in Health and Longevity at Harvard Medical School, has played a pivotal role in reshaping the contemporary understanding of testosterone therapy. Once shunned over fears it fueled prostate cancer, testosterone treatment has been rehabilitated through decades of Morgentaler’s clinical work and research, which demonstrated its safety and meaningful benefits for men with low testosterone. His pioneering efforts helped overturn long-held misconceptions, leading to broader acceptance of testosterone therapy for appropriate patients and a renewed focus on evidence-based care. Read the full STAT News interview here.
How Testosterone Fell Out of Favor in Medicine — and How It Came Back
Learn More
Discover the cutting-edge science we fund
Providing many of the world's best researchers, scientists, and universities with support, and funding to discover breakthroughs that solve humankind's greatest challenges.
See how we support great cultural institutions around the world
The Foundation contributes to renowned institutions that showcase the breadth of arts and culture, including performance, exhibition and education.
Visit the Blavatnik Archive
The Blavatnik Archive is a nonprofit foundation dedicated to preserving and disseminating materials that contribute to the study of 20th-century Jewish and world history, with a special emphasis on World War I, World War II, and Soviet Russia.